Replimune (REPL) Equity Ratio (2018 - 2025)
Replimune has reported Equity Ratio over the past 8 years, most recently at 0.63 for Q4 2025.
- Quarterly results put Equity Ratio at 0.63 for Q4 2025, down 21.02% from a year ago — trailing twelve months through Dec 2025 was 0.63 (down 21.02% YoY), and the annual figure for FY2025 was 0.75, down 1.77%.
- Equity Ratio reached 0.63 in Q4 2025 per REPL's latest filing, down from 0.68 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.92 in Q1 2021 and bottomed at 0.63 in Q4 2025.
- Median Equity Ratio over the past 5 years was 0.84 (2023), compared with a mean of 0.82.
- The largest annual shift saw Equity Ratio grew 17.01% in 2021 before it dropped 21.02% in 2025.
- Over 5 years, Equity Ratio stood at 0.9 in 2021, then fell by 2.68% to 0.88 in 2022, then fell by 9.85% to 0.79 in 2023, then increased by 1.03% to 0.8 in 2024, then dropped by 21.02% to 0.63 in 2025.
- Business Quant data shows Equity Ratio for REPL at 0.63 in Q4 2025, 0.68 in Q3 2025, and 0.72 in Q2 2025.